Trial Information

Summary: Research on ADHD and Smoking

A Pilot Study Of Osmotic Release Methylphenidate (OROS-MPH) In Initiating And Maintaining Abstinence In Smokers With Attention Deficit Hyperactivity Disorder.

You may be eligible to participate in a research study on an investigational medication that may help reduce symptoms of Attention Deficit Hyperactivity Disorder (ADHD) and may also help you to stop smoking.

In addition, you will receive smoking treatment using the nicotine patch and counseling.

Patient Inclusion Criteria

Are you a smoker who:

  • Wants to quit smoking
  • Is 18-55 years old
  • Is easily distracted, forgetful, impulsive, and/or fidgety

Contact:

Victoria Salzman, Assistant Research Scientist
Columbia University Medical Center
The Smoking Cessation Program
New York State Psychiatric Institute
1051 Riverside Drive, Room 2728
New York, NY 10032
Telephone: 212-543-5905
Fax: 212-543-6835
Email:

Profile Page: Columbia University Medical Center, New York, NY

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:46:16 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA